Medicus Pharma Seeks Blank-Cheque Preferred Shares and Up-to-50:1 Forward Split at Dec 2 Meeting

summarizeSummary

Medicus Pharma scheduled a December 2 special meeting to approve an unlimited class of blank-cheque preferred shares and a forward split of up to 50-for-1 — potentially reversing the 50-to-1 consolidation completed October 12. Neither proposal issues shares; both are authorizations.

check_boxKey Events · Corporate Governance and Compliance · MDCX

• Forward Split Up to 50-for-1 Proposed

  Board would set the ratio at its discretion, up to one pre-split share for every 50 post-split shares — at the maximum, substantially reversing the 50-to-1 consolidation completed October 12, 2026.

• Blank-Cheque Preferred Class Proposed

  An unlimited number of Class A Preferred Shares issuable in series, with the board fixing dividend, liquidation, conversion and voting terms without further shareholder approval. No preferred shares are currently outstanding.

• Nasdaq Bid Price Risk Flagged

  The filing states a split near the maximum ratio could push the share price below Nasdaq's $1.00 minimum bid, undoing the compliance the October consolidation was meant to restore.

• 1.89M Shares Outstanding Post-Consolidation

  Only 1,891,826 common shares were outstanding as of October 16, 2026; the board cites the small count as the reason for seeking broader trading liquidity and financing flexibility.

auto_awesomeAnalysis · MDCX · Life Sciences

Six days after completing a 50-to-1 reverse split to hold Nasdaq's $1.00 bid, Medicus is asking shareholders to authorize a forward split of up to 50-for-1 — which at the maximum ratio would substantially undo the consolidation. The stated rationale is that only 1,891,826 shares are outstanding post-consolidation, and a larger share count would support liquidity and give the board room to price future financings and equity awards. The company itself flags the risk: a split near the maximum could push the bid back below $1.00 and jeopardize the Nasdaq listing it just fixed. The second proposal, an unlimited class of blank-cheque Class A preferred shares, hands the board power to set dividend, liquidation, conversion and voting terms without further shareholder votes — useful for raising capital quickly, but it also creates a senior security that can be placed ahead of common holders and carries an anti-takeover effect. Both are authorizations only: no preferred shares exist and no split has been effected. With going-concern doubt, a widened $11.7M Q2 loss and a history of heavy ATM dilution, the practical read is that the company is building instruments for its next capital raise.